They want to bring the ability to write DNA to every lab with their desktop automated gene synthesis platform, Digital-to-biological converter™ (DBC DBC 0.0%).

We are confident that our next generation of enzymatic DNA synthesis printers will be successful in democratizing access to high-fidelity, low-cost nucleic acids.” About DNA Script ...

DNA assembly is commonly performed in the build step of the design-build-test-learn cycle at the core of synthetic biology. In many assembly workflows, DNA is assembled into gene fragments, which ...

DNA Script is disrupting DNA synthesis in more than one way. The company is the maker maker 0.0% of the world's first benchtop DNA printer, SYNTAX, which was released in June 2021.

DNA Script, a pioneer in Enzymatic DNA Synthesis (EDS) and DNA printing on demand, today announced it has raised $165 million in a Series C financing.

That is how Harold P. de Vladar, CEO and founder of long-synthetic DNA service provider Ribbon Biolabs, sees the vast opportunity in the DNA synthesis space. de Vladar says that the DNA synthesis ...

Camena’s gSynth™ platform is revolutionising the DNA synthesis market by unlocking access to genes and accelerating discovery pipelines.'' Steve Harvey, CEO, Camena Bioscience ...